Adicet Bio (ACET) Treasury Shares (2017 - 2026)

Adicet Bio's Treasury Shares history runs 10 years deep, the most recent figure standing at $74503.0 for Q1 2026.

• In Q1 2026, Treasury Shares fell 91.85% year-over-year to $74503.0; the TTM figure through Mar 2026 stood at $74503.0 (down 91.85% YoY), while the FY2025 annual figure was $46842.0, up 4.21% from the prior year.
• Treasury Shares for Q1 2026 stood at $74503.0, up from $46842.0 in the prior quarter.
• The five-year high for Treasury Shares was $914248.0 in Q1 2025, with the low at $44951.0 in Q4 2024.
• The 5-year median for Treasury Shares is $586800.0 (2023), against an average of $531294.6.
• The sharpest annual moves came in 2023 and 2026: Treasury Shares jumped 129.88% in 2023, then slumped 91.85% in 2026.
• Adicet Bio's Treasury Shares stood at $197580.0 in 2022, then surged by 129.88% to $454200.0 in 2023, then plunged by 90.1% to $44951.0 in 2024, then advanced by 4.21% to $46842.0 in 2025, then jumped by 59.05% to $74503.0 in 2026.
• Business Quant data shows ACET's Treasury Shares at $74503.0 in Q1 2026, $46842.0 in Q4 2025, and $759773.0 in Q3 2025.